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Abstract 
Modern biotechnology is a potential technology to be developed in Malaysia. Advancement in molecular genetics 
methods such as the recombinant DNA techniques in genetic engineering improves ways to make use of living 
organisms to benefit human. From the perspectives of agro biotechnology, the methods which enable the introduction 
of genetic material to be integrated into plant genome called Plant Genetic Modified Technology (PGMT). Since 
1980s Malaysia enthusiastically worked on the development of Genetically Modified (GM) Crops. However, with 
certain barriers and hindrances, the successful development seems unattainable. This study was conducted to explore 
the six critical factors and issues which affect the successful commercialization of GM Crops in Malaysia using face 
to face and telephone interview which involved ten respondents from eight universities and research institutions in 
Malaysia. The data was analyzed using NVIVO computer software. The results from findings, recommendations and 
implications to practitioners presented. 
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1. Introduction 
Innovation is the vital aspect to be considered as Malaysia shifts towards Knowledge-Based Economy 
(K-Based Economy) by 2020. Conventionally, with the focus on capital investment, Malaysia seems to be 
far behind countries like China and India with technology and knowledge driven economy (MOSTI, 
2005). Regards to comment above, the chain of creation, research, development and commercialization 
seem to be the headline of many innovation based industries such as biotechnology and nanotechnology 
all over the world (AlangEndut, 2007).  
Hence, Malaysia emphasis on Malaysia Biotechnology Policy which lines up three stages, Phase I 
(2005-2010) for capacity building, Phase II (2011-2015) for science to business transition and Phase III 
(2016-2020) for global presence (MOSTI, 2005). From the perspective of agriculture, modern genetics 
enhance many agricultural activities in terms of producing high quality seeds using tissue culture and 
hybrid, bio fuels, biotech seeds, bio-pesticides, and bio-fertilizer (Paul, 2008). The Genetic Modification 
(GM) Technology is a method of transferring a fraction of DNA sequences coded a particular gene into 
particular organism. This method is to induce genetic composition alteration which affects the phenotype 
of the organism. Hence it will produce desired traits or characteristics of transgenic organism (Brooker, 
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2005). To develop a productive agricultural industry in Malaysia, it is crucial to develop the transgenic 
plants from the laboratory to the real market.  
 
2. Literature Review 
 
Malaysia has been dealing with GM crops activities since 1985 (Abubakar, 2007). Nevertheless the 
GM crops study eagerly started from 2000 until today without any successful commercialized GM crops 
product. Originally, the purpose of starting the GM study at the moment was to overcome the limitations 
of conventional breeding and improved efficiency of tissue culture activity (MABIC, 2006). According to 
Ellis (2006), Malaysia currently enthusiastically worked on virus-resistant transgenic rice, papaya, chili 
and quality enhance of transgenic palm oil and pineapple. While considered Malaysia Agricultural 
Research Development Institute (MARDI) as the key player of this industry, MARDI continued their 
research on GM crops since 2000 with developing virus resistance chili pepper, passion fruits, orchids, 
rice and papaya which are based on agronomic trait. But until today, the significance of GM crops under 
research is limited to rice and papaya (Abubakar, 2007; Ellis, 2006; MABIC, 2006). 
The scenario in Malaysia is supported by Kalaitzandonake et. al (2007) who concluded three major 
obstacles which slow down the innovation activities of transgenic crops which are the lethargic moves of 
regulatory approval, decrease research and development intensity towards lower market potential crops 
and lacking of establishment of new biotech firm. In this study, the indices of the problems affecting GM 
development and commercialization are based on the perspectives and views of different entities. The 
opinion of human and financial capital and other requirements (Cohen, 2005; Valvaseyi, 2005; Ismail,et 
al.,2011a;b;c), bio safety regulation (Cohen, 2005; Kalaitzandonakes et al., 2007; Ethugala, 2011), and 
public acceptance (Februhartanty et al, 2007; Ismail et al., 2011a), Intellectual property protection (Paul, 
2008; Ismail et al., 2011b), institutional roles (Cohen, 2005; Paul, 2008; Ismail et al., 2011b), technical 
constraint (Valyasevi, 2005) may have views on the different perspectives of the main key player. 
 
3. Research Methodology 
 
Eight institutions in Malaysia either directly or indirectly involved in GM crops development were 
covered; two ministries, Ministry of National Resources Environment (NRE) and Ministry of Agriculture 
(MOA), two Government Research Institute (GRI)s; Malaysia Agricultural Research and Development 
Institute (MARDI) and Malaysia Palm Oil Board (MPOB) and four universities ; Universiti Putra 
Malaysia (UPM), Universiti Teknologi Mara (UiTM), Universiti Teknologi Malaysia (UTM) and 
Universiti Kebangsaan Malaysia (UKM).Respondents are researchers, regulators and administrative 
personnel. Non probability sampling method was preferred as it enables the researcher gain in debt 
information from diverse respondents from a variety of background. Although the sample population is 
little, it is consistent with Ritchie and Lewis (2003) opinion that qualitative samples may be little in size, 
but the yield is usually rich in details. Two modes of interview were used in this study; the face to face 
and telephone interview. From the feedback, the main factors mostly highlighted by respondents are, 
issues on the human and financial capital and other capital requirements and institutional roles which 
scored 90% of feedback. In contrast, the less concerned issues were the bio-safety regulatory issues and 
intellectual property protection with only 40%.  
 
Table 1: Summary of the Findings (Compiled from the interview) 
 
No Issues/ 
respondents 
M1 M2 M3 M4 R1 R2 R3 R4 R5 R6 Percent
age 
1 Human Capital and 
Other Capital 
Requirements 
 ¥ ¥ ¥ ¥ ¥ ¥ ¥ ¥ ¥ 90% 
2  Bio safety 
Regulation 
¥ ¥   ¥  ¥    40% 
3 Institutional Roles ¥ ¥ ¥ ¥ ¥ ¥ ¥ ¥ ¥ 90%
4 Intellectual Property 
Protection 
  ¥ ¥ ¥    ¥  40% 
5 Technical     ¥ ¥ ¥ ¥ ¥ ¥ 60% 
6 Public acceptance ¥ ¥    ¥  ¥  ¥ 50% 
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Success or lack of success was the denomination given by the respondent, who compared the effects of 
commercialization in relation to the GM crops regarding the 21 sub-elements included in six major factors. 
In agreement with the methodology, each main component corresponds to a set of isolated variables, 
which by applying the multivariate analysis technique were reduced, aiming at facilitating data 
interpretation. Some isolated variables considered are equally significant for all the sectors and it enables 
examining similarity and differences between the sectors.  
In the cases where the performance was equal or surpassed expectations, they were classified as the 
factors that affect the performance on commercialization of GM crops. They are limited numbers of 
researcher, inexperienced researcher, limited funding and grant, collaboration issues, less intention to 
commercialize the product, issues on Discovery Phase (gene and trait identification), issues on Phase I 
(proof of concept) and knowledge and awareness. In opposition, data revealed that researchers and 
management personnel are lacking of interest and awareness on ownership issues of intellectual property 
protection. Protection is very important because these exclusive rights allow owners of intellectual 
property to benefit from the property they have created, providing a financial incentive for the creation of 
an investment in intellectual property, and, in case of patents, pay associated research and development 
costs. 
 
 
 
 
 
 
 
 
5. Discussion 
 
 
 
 
 
 
 
Figure 1: A modified TengkuAzhar Model on Problems on Commercialization of GM crops in Malaysia. 
 
In Malaysia, researches on GM crops have been conducted since 1980s. However, the successful 
commercialization of GM crops still has a long way to go if compared to (MABIC, 2006), China, India, 
Argentina, Brazil and South Africa. All institutions were directly or indirectly involved in the 
commercialization GM crops. Besides the outlined institutions, the respondents also discovered other 
players such as the Ministry of Science, Technology and Innovation (MOSTI), Ministry of Health (MOH), 
other Government Research Institutes (GRI) such as Agro Biotechnology Institution (ABI), other public 
universities, private biotechnology organizations and the Non-Governmental Organizations (NGOs). 
Ministries were responsible to provide sufficient grant and funding (Ismail et al., 2011b; Ismail et al., 
2011d), policy, convenience environment, opportunity and support for the capacity building. Public 
universities, private biotechnology organization and the Non-Governmental Organizations (NGOs) play 
their roles more on implementation for the continuity of the product development. The six most crucial 
factors were confirmed to affect the development of GM crops issues. Capital requirement at the early 
stage of product development  is vital to overcome the insufficiency capabilities such as the expertise, 
knowledge and facilities. Such issues reflected so much especially to the technical constraints factors. 
 
The same scenario occurred for regulatory issues. In this study, the regulatory issues were related to 
Bio safety regulation and the Intellectual property (IP) protection factors. The efficiency of resources 
allocation especially in terms of the funding determined the successful establishment and implementation 
of the regulation. On the other hand, the institutions are also responsible to the public acceptance issues, to 
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persuade and educate the public to solve the issues on knowledge, awareness and perception towards the 
product. 
 
4. Conclusions and Recommendations 
 
With a deeper understanding of the critical issues, the effort to tackle the issues becomes easier. With 
the combination of the previous study and this study finding, the study had answered all the research 
questions which include the identification of factors that can affect the commercialization process of GM 
crops, determination of the most important factors and key players on successful commercialization 
process of GM crops. 
Although important technology has been developed primarily in the industrialized countries, the better 
utilization sites are likely to be found elsewhere-largely in the tropics and southern hemisphere and 
developed perhaps through joint technology contracts. Additionally, much of the basic research necessary 
for the development of genetically modified crops has already been completed and is part of shared 
knowledge in the scientific community. The techniques for applying genetic engineering to crops are well 
known and, in fact, being used in laboratories and field tests around the world. Many of the remaining 
challenges to commercialization and deployment are associated with deregulation and public acceptance. 
As a conclusion, the study showed that all the six factors were significant to the GM crops 
development. However, the views of the issues were only based on the early phase of the GM 
development parallel to its current development stage in Malaysia. Policy makers and practitioners should 
be guided by these recommendations; 
a) Institutions should collaborate to form intensive and centralize GM crop research group with 
focus on potential to commercialize varieties. 
b) Increase awareness and knowledge about the product through educational programs and 
media (television and radio program, text book syllabus, seminar etc). 
c) Increase the awareness to commercialize the product by promoting the university research 
and focus towards production. 
d) Heavily enforced the establishment and collaboration of institutions, unit and bodies to 
coordinate the regulation and activities. 
e) Improve funding allocation for capacity building to minimize the distraction of resource 
limitations. 
 Finally, a model was proposed based on the findings of the study which is consistent with the 
Monsanto model, with the six major factors as discussed earlier.  
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